Bronchiectasis: Evaluation of an Educational Intervention

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Hill-Rom

No Placebo Group

Trial Summary

What is the purpose of this trial?

A study of an educational intervention of primary care practice physicians to assist in the identification of patients who have Bronchiectasis and to assess the effectiveness of the specific didactic educational intervention targeting primary care physicians in the recognition of Bronchiectasis.

Research Team

Eligibility Criteria

Inclusion Criteria

Respiratory is the chief complaint

Patient > 35 years of age

Seen in practice for > 12 months

Treatment Details

Interventions

Primary Care Educational event (Behavioural Intervention)

Participant Groups

3Treatment groups

Experimental Treatment

Group I: Seasonal prior yearExperimental Treatment1 Intervention

As respiratory illnesses are commonly seasonal, an assessment of rate of Bronchiectasis diagnosis during the months of Period 2 in the year prior to the educational intervention will also be assessed as described in Period 1

Group II: Immediately preceding interventionExperimental Treatment0 Interventions

3 months immediately before the education event. Charts of patients with a primary respiratory complaint will be reviewed so evaluate if they 1) have experienced 3 or more suppurative respiratory infections and 2) have required 3 or more courses of antibiotic therapy for respiratory infection over the period of one year. 4) Whether or not they underwent a HRCT, and if so, and 5) Were the patients diagnosed with BE.

Group III: 3 months after educational eventExperimental Treatment1 Intervention

3 months immediately after the education event. An active assessment will be preformed as per the proposed diagnostic algorithm (attachment B) Patients that meet all criteria in the algorithm are considered at risk for bronchiectasis and based on these criteria, physicians will be encouraged to order HRCT, and the number/ proportion of patients identified with BE will be noted and compared to the other time periods.